🇺🇸 FDA
Patent

US 8470816

Nitrogen-containing heterocyclic compound and use thereof

granted A61PA61P1/00A61P13/00

Quick answer

US patent 8470816 (Nitrogen-containing heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61P, A61P1/00, A61P13/00, A61P25/00